SN Compr Clin Med. 2020 Aug 21:1-2. doi: 10.1007/s42399-020-00462-2. Online ahead of print.
ABSTRACT
In this letter, we discuss the potential interactions of remdesivir, the newly approved Covid-19 drug with pulmonary medications. These interactions have been summarized keeping the busy clinician in mind. While remdesivir has proven to be a safe medication generally, we here have enlisted the potential interactions of remdesivir that a clinician needs to be mindful of while prescribing the medication.
PMID:32864571 | PMC:PMC7441835 | DOI:10.1007/s42399-020-00462-2